Your browser doesn't support javascript.
loading
Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.
Wilcox, Naomi; Dumont, Martine; González-Neira, Anna; Carvalho, Sara; Joly Beauparlant, Charles; Crotti, Marco; Luccarini, Craig; Soucy, Penny; Dubois, Stéphane; Nuñez-Torres, Rocio; Pita, Guillermo; Gardner, Eugene J; Dennis, Joe; Alonso, M Rosario; Álvarez, Nuria; Baynes, Caroline; Collin-Deschesnes, Annie Claude; Desjardins, Sylvie; Becher, Heiko; Behrens, Sabine; Bolla, Manjeet K; Castelao, Jose E; Chang-Claude, Jenny; Cornelissen, Sten; Dörk, Thilo; Engel, Christoph; Gago-Dominguez, Manuela; Guénel, Pascal; Hadjisavvas, Andreas; Hahnen, Eric; Hartman, Mikael; Herráez, Belén; Jung, Audrey; Keeman, Renske; Kiechle, Marion; Li, Jingmei; Loizidou, Maria A; Lush, Michael; Michailidou, Kyriaki; Panayiotidis, Mihalis I; Sim, Xueling; Teo, Soo Hwang; Tyrer, Jonathan P; van der Kolk, Lizet E; Wahlström, Cecilia; Wang, Qin; Perry, John R B; Benitez, Javier; Schmidt, Marjanka K; Schmutzler, Rita K.
Affiliation
  • Wilcox N; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Dumont M; Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, Quebec, Canada.
  • González-Neira A; Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Carvalho S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Joly Beauparlant C; Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, Quebec, Canada.
  • Crotti M; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Luccarini C; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Soucy P; Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, Quebec, Canada.
  • Dubois S; Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, Quebec, Canada.
  • Nuñez-Torres R; Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Pita G; Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Gardner EJ; MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Alonso MR; Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Álvarez N; Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Baynes C; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Collin-Deschesnes AC; Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, Quebec, Canada.
  • Desjardins S; Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, Quebec, Canada.
  • Becher H; Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Castelao JE; Oncology and Genetics Unit, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
  • Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cornelissen S; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Dörk T; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Engel C; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Gago-Dominguez M; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
  • Guénel P; LIFE-Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
  • Hadjisavvas A; Cancer Genetics and Epidemiology Group, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) Foundation, Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
  • Hahnen E; Team 'Exposome and Heredity,' CESP, Gustave Roussy, INSERM, University Paris-Saclay, UVSQ, Villejuif, France.
  • Hartman M; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
  • Herráez B; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Jung A; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore City, Singapore.
  • Keeman R; Department of Surgery, National University Health System, Singapore City, Singapore.
  • Kiechle M; Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.
  • Li J; Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Lush M; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Michailidou K; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Panayiotidis MI; Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
  • Sim X; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore City, Singapore. lijm1@gis.a-star.edu.sg.
  • Teo SH; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
  • Tyrer JP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • van der Kolk LE; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Wahlström C; Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
  • Wang Q; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
  • Perry JRB; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore City, Singapore.
  • Benitez J; Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Malaysia.
  • Schmidt MK; Department of Surgery, Faculty of Medicine, University of Malaya, UM Cancer Research Institute, Kuala Lumpur, Malaysia.
  • Schmutzler RK; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Nat Genet ; 55(11): 2009, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37752376
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2023 Document type: Article Affiliation country: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2023 Document type: Article Affiliation country: Reino Unido